Search Results
Dr. Philip Discusses the Use of Lutathera in NETs
Dr. Philip Discusses Research Questions With Lutathera in NETs
Dr. Philip on Adverse Events With Lutathera in NETs
Improving PRRT for Neuroendocrine Tumors (NETs)
Dr. Wolin on the Safety Profile of Lutathera in Advanced NETs
Dr. Strosberg on FDA Approval of Lutathera for GEP-NETs
Dr. Jonathan R. Strosberg on the NETTER-1 Trial and its Impact on Patients With Midgut NETs
Dr. Chauhan on the Role of 177Lu-Dotatate in NETs
FDA-Approved Novel Agent Appears Promising in GEP-NETs
Dr. Strosberg on Retreatment With 177Lu-Dotatate in Advanced NETs
Lutathera Therapy: Targeted Internal Radiation
Dr. Strosberg on the Results of the NETTER-1 Trial
